Dynavax Technologies (NASDAQ: DVAX)

8d ago, source: The Motley Fool

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics.

Dynavax Technologies: Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates

1d ago, source:

HEPLISAV-B® vaccine net product revenue grew 10% year-over-year to approximately $48 million in the first quarter of 2024 Reaffirming full year 2024 HEPLISAV-B net product revenue guidance of $265 - ...

Dynavax Technologies Corp DVAX

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates

2d ago, source: Yahoo Finance

May 8, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported ...